Christopher Hunt Keir
Christopher Hunt Keir publishes mostly in Pulmonary and Respiratory Medicine, Gastroenterology and Oncology, on topics such as Gastrointestinal Tumor Research and Treatment, Gastric Cancer Management and Outcomes and Chronic Myeloid Leukemia Treatments.
- World rank
- #2,508,779 of 7,710,434 ranked researchers
- Rank in United States
- #739,467 of 1,627,098
- Works
- 43
- Citations
- 2.8k
- Citations per work
- 64.1
What does Christopher Hunt Keir research?
Christopher Hunt Keir's work is mostly in Medicine (74%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3274.2%
- Medicine3274.2%
- Everything else1125.8%
- 1Pulmonary and Respiratory Medicine20% of their works
- 2Gastroenterology15% of their works
- 3Oncology13% of their works
- 4Hematology12% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Surgery6% of their works
Research topics
Which keywords describe Christopher Hunt Keir's research?
The keywords of their largest research topics: Prognostic Factors, Chemotherapy, Clinical Practice Guidelines, Imatinib Mesylate, Sunitinib, Endoscopic Resection, Gastric Cancer and BCR-ABL.
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Osteosarcoma
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Endoscopic Resection
- Imatinib Mesylate
- Chemotherapy
- Prognostic Factors
- Clinical Practice Guidelines
- Sunitinib
- Gastric Cancer
- Imatinib
- CAR T Cells
- Chimeric Antigen Receptor
- Soft Tissue Sarcoma
- EGFR Mutations
- Targeted Therapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors304 topics
- Chemotherapy172 topics
- Clinical Practice Guidelines172 topics
- Imatinib Mesylate151 topic
- Sunitinib151 topic
- Endoscopic Resection121 topic
- Gastric Cancer121 topic
- BCR-ABL101 topic
- Imatinib101 topic
- Acute Lymphoblastic Leukemia61 topic
- CAR T Cells61 topic
- Childhood Cancer61 topic
- Chimeric Antigen Receptor61 topic
- Osteosarcoma51 topic
- Soft Tissue Sarcoma51 topic
- Chronic Lymphocytic Leukemia41 topic
- EGFR Mutations41 topic
- Genomic Aberrations41 topic
- Targeted Therapy41 topic
Where does Christopher Hunt Keir work?
Christopher Hunt Keir's main affiliation in the publication record is Analysis Group (United States), United States.
How many publications and citations does Christopher Hunt Keir have?
OpenAlex counts 43 works and 2,756 citations for Christopher Hunt Keir, an h-index of 14, ranking #2,508,779 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christopher Hunt Keir. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.